Autonomus Medical Technologies, Inc.

Cambridge, MA

UEI
GXJ9RAMNLP96
CAGE
973S3
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
750 Main St, Cambridge, MA 02139, USA
Website
autonomus.ai
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $2,000,000
FY2025 $1,319,186
FY2024 $0
FY2023 $74,134

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Air Force $2,000,000

Contract awards

Grant subawards

Prime recipient Prime award Amount Awarded
The Johns Hopkins University Hip fractures are a leading cause of morbidity and mortality among older adults, with over 300,000 U.S. cases annually [1]. Despite strong evidence supporting… U54EB033664 $1,112,413

Similar vendors

About the company

Autonomus Medical Technologies, Inc. is a for-profit corporate entity based in Cambridge, Massachusetts, specializing in advanced medical technology research and development for challenging medical interventions in austere environments. Registered in the System for Award Management (SAM) since October 2021, the company focuses on innovative medical device solutions that leverage artificial intelligence and robotic technologies to enable non-specialist medical personnel to perform complex medical procedures in high-stress or resource-limited settings.

The company has secured multiple Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) contracts exclusively with the Air Force Research Laboratory, targeting critical medical intervention technologies. These contracts, ranging from $74,134 to $1,211,000, focus on developing semi-autonomous medical devices for specialized interventions such as nerve block administration, vascular access, and hemorrhage treatment. Each contract is designated as a Total Small Business set-aside and involves developing advanced technological solutions like a handheld robotic medical device for nerve block administration, a semi-autonomous device for rapid vascular access, and an artificial intelligence-guided ultrasound intervention device for treating noncompressible hemorrhage. The research projects are designed to empower non-specialist medical personnel to perform complex medical procedures in austere environments, demonstrating the company's commitment to enhancing medical capabilities in challenging operational contexts.

Quick answers

Is Autonomus Medical Technologies, Inc. registered in SAM.gov?

Yes. Autonomus Medical Technologies, Inc.'s SAM.gov registration is active through January 12, 2027.

How much has Autonomus Medical Technologies, Inc. received in federal contracts?

Federal contracts obligated $1,319,186 to Autonomus Medical Technologies, Inc. in fiscal year 2025 and $3,393,320 in fiscal years 2023 through 2027.

What is Autonomus Medical Technologies, Inc.'s most recent federal award?

Autonomus Medical Technologies, Inc.'s most recent federal contract award is Handheld robotic medical device for semi-automated nerve block administration in austere environments (FA864925P0184), from Air Force Research Laboratory (AFMC), on February 10, 2025.

On GovTribe

See Autonomus Medical Technologies, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors